Failure After Assisted Reproductive Technology
Conditions
Keywords
TCM multi-channel therapy, ART failure
Brief summary
Objective: To evaluate the curative effect of TCM multi-channel interventional therapy on women with ART Failure; to compare the curative effect of the dual therapy and triple therapy on women with ART Failure; to choose the best TCM interventional therapeutic plan. Methods: The cases with ART Failure from West China second University Hospital of Sichuan University (West China Women's and Children's Hospital of Sichuan University) meeting the inclusion criteria were randomly divided into three groups: the dual therapy group, the triple therapy group and the control group, compare the natural pregnancy number, the condition during the period of secondary IVF-ET and the improvement of the kidney deficiency, liver depression and blood stasis syndrome among those three groups.
Detailed description
Objective: To evaluate the curative effect of TCM multi-channel interventional therapy on women with ART Failure; to compare the curative effect of the dual therapy and triple therapy on women with ART Failure; to choose the best TCM interventional therapeutic plan. Methods: The cases with ART Failure from West China second University Hospital of Sichuan University (West China Women's and Children's Hospital of Sichuan University) meeting the inclusion criteria were randomly divided into three groups: the dual therapy group, the triple therapy group and the control group, compare the natural pregnancy number, the condition during the period of secondary IVF-ET and the improvement of the kidney deficiency, liver depression and blood stasis syndrome among those three groups. The results will show the effect of TCM multi-channel interventional therapy for patients with ART failure
Interventions
OTHERThe dual therapy
TCM prescriptionⅡof cultivated emotion and assisted reproduction +auricular acupoint therapy
OTHERThe triple therapy
TCM prescriptionⅡof cultivated emotion and assisted reproduction + auricular acupoint therapy+ retention enema of TCM
Sponsors
Chengdu University of Traditional Chinese Medicine
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
20 Years to 42 Years
Healthy volunteers
No
Inclusion criteria
1. People aged 20 to 42 2. People with IVF - ET indications 3. People from Reproductive Center of West China second University Hospital of Sichuan University (West China Women's and Children's Hospital of Sichuan University) with long plan for IVE - ET Failure and then accept the secondary IVF-ET 4. People who conform to the standard of syndrome differentiation in TCM: kidney deficiency and liver depression and blood stasis 5. People with normal basic sex hormone levels 6. People who have recognized and voluntarily signed the informed consent. NOTICE: People who conform to the above 6 items can be included.
Exclusion criteria
1. People don't meet the inclusion criteria 2. The husband with less sperm and weak sperm seriously 3. People who have drug allergy or allergic constitution 4. People with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, etc. And mentally disordered patients 5. People who are complicated by acute infectious diseases and organic diseases 6. People have confirmed diagnosis malformed reproductive organs, reproductive system inflammation and tumors upon examination 7. People suffer from hereditary disease which is not suitable for fertility regulated in maternal and infant health care law 8. People who have the serious bad habits such as drug use 9. People who have contacted with birth defects rays, poison, drugs to a certain number and being in effect; NOTICE: People who conform to any of the terms above 9 will be ruled out.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients with successful conception | 10 weeks after embryo transplantation |
Secondary
| Measure | Time frame |
|---|---|
| Time to have successful conception | up to 26 weeks |
| Adverse events | 0, 10, 26 weeks after randomization |
Countries
China
Outcome results
None listed